Related Experiment Videos
Urinary beta 2 microglobulin in upper and lower urinary-tract infections
Lancet (London, England)
|April 14, 1979
Summary
Beta 2-microglobulin levels can help differentiate upper urinary tract infections from lower ones like cystitis. However, this marker is unreliable with pre-existing kidney tubule damage, and urine pH must be above 6.0 for accurate testing.
Area of Science:
- Nephrology
- Clinical Biochemistry
- Infectious Diseases
Background:
- Urinary tract infections (UTIs) are common, with upper UTIs potentially leading to severe complications.
- Distinguishing between upper and lower UTIs is crucial for appropriate treatment and management.
- Biomarkers are needed to accurately diagnose the location of UTIs.
Purpose of the Study:
- To evaluate the utility of beta 2-microglobulin (B2M) in differentiating upper vs. lower urinary tract infections.
- To assess the influence of pre-existing tubular damage and urine pH on B2M levels.
Main Methods:
- Collected 24-hour urine samples from patients with upper UTIs and cystitis.
- Measured beta 2-microglobulin excretion and calculated beta 2-microglobulin clearance.
- Analyzed urine pH in relation to B2M degradation.
Main Results:
- Significantly increased B2M excretion and clearance were observed in patients with upper UTIs.
- Normal B2M excretion and clearance were found in patients with cystitis.
- B2M degradation in the bladder was noted at pH levels below 6.0.
Conclusions:
- Beta 2-microglobulin estimation can distinguish upper from lower UTIs, provided no pre-existing tubular damage is present.
- Accurate B2M testing requires urine pH to be maintained above 6.0 to prevent degradation.
- B2M serves as a potential diagnostic marker for localized UTIs.